Universal Corporation, a global agriproducts company focused on tobacco leaf supply and plant-based ingredients, is currently trading at very low valuations. Recent declines in revenue and profits are due to temporary tobacco oversupply and delayed customer purchases, but management expects recovery in the second half of 2027. Long-term growth is anticipated from the plant-based Ingredients Operations segment, although recent investments are still maturing. The company remains a soft 'buy' despite industry headwinds, reflecting potential value for investors.
Universal Corporation's valuation is notably low amid its current challenges. For readers following Universal Corporation, here is Pluang's market snapshot as of Sep 30, 2026 22:51 WIB: Among 38 priced Basic Materials-sector US stocks tradable on Pluang, 20 rose and 18 fell today. Notable price changes include ICL at USD 5.05 (-2.32%), TECK at USD 66.03 (+1.82%), and AVNT at USD 40.10 (-1.66%).
Lloyds and Visa have successfully completed a pilot project that settled $750,000 using USD Coin (USDC) for cross-border payments. This demonstrates the growing adoption of stablecoins like USDC in international transactions, offering faster and pote...
Bitcoin's price briefly surged to $85,600 following the release of U.S. August personal consumption expenditures (PCE) inflation data, signaling a market reaction to inflation news. Shortly after, the price fell back to $84,350. During the four hours...
In September, Aave V4's total value locked (TVL) surged by 82%, indicating strong growth and increased user engagement on the platform. During the same period, Arc achieved a significant milestone by reaching $181 million in TVL. These figures highli...
Duke Energy and its Foundation awarded $326,500 in grants to 27 organizations across Florida to support workforce development, business growth, and economic development. The funds will be used for projects like updating economic plans, deploying new ...
The Rule of 20 valuation metric indicates the S&P 500 is currently overvalued with a P/E ratio of 26x and inflation at 3.4%, resulting in a score near 30, above historical norms. This overvaluation is compounded by ongoing inflation, record corporate...
